These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 32759882)

  • 21. Mechanistic basis for type 2 long QT syndrome caused by KCNH2 mutations that disrupt conserved arginine residues in the voltage sensor.
    McBride CM; Smith AM; Smith JL; Reloj AR; Velasco EJ; Powell J; Elayi CS; Bartos DC; Burgess DE; Delisle BP
    J Membr Biol; 2013 May; 246(5):355-64. PubMed ID: 23546015
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Functional Invalidation of Putative Sudden Infant Death Syndrome-Associated Variants in the
    Smith JL; Tester DJ; Hall AR; Burgess DE; Hsu CC; Elayi SC; Anderson CL; January CT; Luo JZ; Hartzel DN; Mirshahi UL; Murray MF; Mirshahi T; Ackerman MJ; Delisle BP
    Circ Arrhythm Electrophysiol; 2018 May; 11(5):e005859. PubMed ID: 29752375
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Novel
    Cheng YW; Wu CT; Chang CJ; Yeh YH; Chang GJ; Tsai HY; Hsu LA
    Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37628921
    [No Abstract]   [Full Text] [Related]  

  • 24. Genetic testing for long-QT syndrome: distinguishing pathogenic mutations from benign variants.
    Kapa S; Tester DJ; Salisbury BA; Harris-Kerr C; Pungliya MS; Alders M; Wilde AA; Ackerman MJ
    Circulation; 2009 Nov; 120(18):1752-60. PubMed ID: 19841300
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nonsense-Mediated mRNA Decay of hERG Mutations in Long QT Syndrome.
    Gong Q; Zhou Z
    Methods Mol Biol; 2018; 1684():37-49. PubMed ID: 29058182
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Derivation and characterization of two human induced pluripotent stem cell lines (NUIGi004-A) and (NUIGi012-A) from two patients with LQT2 disease.
    Liu M; Ge N; Zhang J; Yang M; Yang F; Krawczyk J; Ward D; McInerney V; O'Brien T; Shen S; Prendiville T
    Stem Cell Res; 2021 Oct; 56():102555. PubMed ID: 34628246
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Utilization of the genome aggregation database, in silico tools, and heterologous expression patch-clamp studies to identify and demote previously published type 2 long QT syndrome: Causative variants from pathogenic to likely benign.
    Mattivi CL; Ye D; Tester DJ; Clemens DJ; Zhou W; Giudicessi JR; Ackerman MJ
    Heart Rhythm; 2020 Feb; 17(2):315-323. PubMed ID: 31493592
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prediction of Kv11.1 potassium channel PAS-domain variants trafficking via machine learning.
    Immadisetty K; Fang X; Ramon GS; Hartle CM; McCoy TP; Center RG; Mirshahi T; Delisle BP; Kekenes-Huskey PM
    J Mol Cell Cardiol; 2023 Jul; 180():69-83. PubMed ID: 37187232
    [TBL] [Abstract][Full Text] [Related]  

  • 29. KCNH2 mutation c.3099_3112del causes congenital long QT syndrome type 2 with gender differences.
    Ke Z; Li C; Bai G; Tan L; Wang J; Zhou M; Zhou J; Chen SY; Dong X
    Clinics (Sao Paulo); 2023; 78():100285. PubMed ID: 37783170
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel characteristics of a trafficking-defective G572R-hERG channel linked to hereditary long QT syndrome.
    Lian J; Huang N; Zhou J; Ge S; Huang X; Huo J; Liu L; Xu W; Zhang S; Yang X; Zhou J; Huang C
    Can J Cardiol; 2010 Oct; 26(8):417-22. PubMed ID: 20931094
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The mutation L69P in the PAS domain of the hERG potassium channel results in LQTS by trafficking deficiency.
    Jenewein T; Kanner SA; Bauer D; Hertel B; Colecraft HM; Moroni A; Thiel G; Kauferstein S
    Channels (Austin); 2020 Dec; 14(1):163-174. PubMed ID: 32253972
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Model for long QT syndrome type 2 using human iPS cells demonstrates arrhythmogenic characteristics in cell culture.
    Lahti AL; Kujala VJ; Chapman H; Koivisto AP; Pekkanen-Mattila M; Kerkelä E; Hyttinen J; Kontula K; Swan H; Conklin BR; Yamanaka S; Silvennoinen O; Aalto-Setälä K
    Dis Model Mech; 2012 Mar; 5(2):220-30. PubMed ID: 22052944
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Advantages, Challenges, and Future of Human-Induced Pluripotent Stem Cell Lines in Type 2 Long QT Syndrome.
    Cai D; Zheng Z; Jin X; Fu Y; Cen L; Ye J; Song Y; Lian J
    J Cardiovasc Transl Res; 2023 Feb; 16(1):209-220. PubMed ID: 35976484
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aborted Cardiac Arrest in LQT2 Related to Novel
    Bileišienė N; Barysienė J; Mikštienė V; Preikšaitienė E; Marinskis G; Keževičiūtė M; Utkus A; Aidietis A
    Medicina (Kaunas); 2021 Jul; 57(7):. PubMed ID: 34357002
    [TBL] [Abstract][Full Text] [Related]  

  • 35. hERG-deficient human embryonic stem cell-derived cardiomyocytes for modelling QT prolongation.
    Chang Y; Li YN; Bai R; Wu F; Ma S; Saleem A; Zhang S; Jiang Y; Dong T; Guo T; Hang C; Lu WJ; Jiang H; Lan F
    Stem Cell Res Ther; 2021 May; 12(1):278. PubMed ID: 33962658
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Generation and characterization of an induced pluripotent stem cell (iPSC) line (NUIGi003-A) from a long QT syndrome type 2 (LQT2) patient harbouring the KCNH2 c.2464G>A pathogenic variant.
    Ge N; Liu M; Krawczyk J; McInerney V; Ward D; Shen S; O'Brien T; Prendiville T
    Stem Cell Res; 2020 Dec; 49():101997. PubMed ID: 33002718
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long QT syndrome-associated mutations in intrauterine fetal death.
    Crotti L; Tester DJ; White WM; Bartos DC; Insolia R; Besana A; Kunic JD; Will ML; Velasco EJ; Bair JJ; Ghidoni A; Cetin I; Van Dyke DL; Wick MJ; Brost B; Delisle BP; Facchinetti F; George AL; Schwartz PJ; Ackerman MJ
    JAMA; 2013 Apr; 309(14):1473-82. PubMed ID: 23571586
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Common variants in the hERG (KCNH2) voltage-gated potassium channel are associated with altered fasting and glucose-stimulated plasma incretin and glucagon responses.
    Engelbrechtsen L; Mahendran Y; Jonsson A; Gjesing AP; Weeke PE; Jørgensen ME; Færch K; Witte DR; Holst JJ; Jørgensen T; Grarup N; Pedersen O; Vestergaard H; Torekov S; Kanters JK; Hansen T
    BMC Genet; 2018 Mar; 19(1):15. PubMed ID: 29548277
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Suppression and Replacement Gene Therapy for
    Bains S; Zhou W; Dotzler SM; Martinez K; Kim CJ; Tester DJ; Ye D; Ackerman MJ
    Circ Genom Precis Med; 2022 Dec; 15(6):e003719. PubMed ID: 36252106
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serine mutation of a conserved threonine in the hERG K
    Al-Moubarak E; Zhang Y; Dempsey CE; Zhang H; Harmer SC; Hancox JC
    Biochem Biophys Res Commun; 2020 Jun; 526(4):1085-1091. PubMed ID: 32321643
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.